BE902796A - Ester d'acetyl carnitine, sa preparation et son utilisation. - Google Patents

Ester d'acetyl carnitine, sa preparation et son utilisation.

Info

Publication number
BE902796A
BE902796A BE0/215287A BE215287A BE902796A BE 902796 A BE902796 A BE 902796A BE 0/215287 A BE0/215287 A BE 0/215287A BE 215287 A BE215287 A BE 215287A BE 902796 A BE902796 A BE 902796A
Authority
BE
Belgium
Prior art keywords
preparation
ester
acetyl carnitine
carnitine
acetyl
Prior art date
Application number
BE0/215287A
Other languages
English (en)
Inventor
C Cavazza
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of BE902796A publication Critical patent/BE902796A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Dichlorure d'acétyl carnitate de carnitine de la formule I : sa préparation et son utilisation sous la forme de composition pharmaceutique pour l'administration orale ou parentérale.
BE0/215287A 1984-07-04 1985-07-02 Ester d'acetyl carnitine, sa preparation et son utilisation. BE902796A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT48503/84A IT1177874B (it) 1984-07-04 1984-07-04 Estere della acetil carnitina,procedimenti per la sua preparazione e composizioni farmaceutiche che lo contengono

Publications (1)

Publication Number Publication Date
BE902796A true BE902796A (fr) 1985-11-04

Family

ID=11266955

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/215287A BE902796A (fr) 1984-07-04 1985-07-02 Ester d'acetyl carnitine, sa preparation et son utilisation.

Country Status (7)

Country Link
US (1) US4743621A (fr)
JP (1) JPS6130560A (fr)
BE (1) BE902796A (fr)
CH (1) CH664561A5 (fr)
DE (1) DE3522534A1 (fr)
IL (1) IL75625A0 (fr)
IT (1) IT1177874B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5418253A (en) * 1992-10-20 1995-05-23 Avantgarde S.P.A. Esters of L-carnitine and alkanoyl L-carnitines with glycolic acid or esters thereof and pharmaceutical compositions containing same for treating dermatoses

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1237343B (it) * 1984-03-28 1993-05-31 Francia Farma Dicloridrato di acetildicarnitina, procedimento per la sua preparazione e composizioni farmaceutiche che lo contengono
GB8707055D0 (en) * 1987-03-25 1987-04-29 Gillette Co Triglyceride quaternary ammonium compounds
DE3726945A1 (de) * 1987-08-13 1989-02-23 Dietl Hans L-carnitinderivate der valproinsaeure und diese enthaltende arzneimittel
IT1240760B (it) * 1990-02-12 1993-12-17 Sigma Tau Ind Farmaceuti Esteri di acil-l-carnitine con l'acido gamma-idrossibutirrico e composizioni farmaceutiche che li contengono per l'inibizione della degenerazione neuronale e nel trattamento del coma.
IT1240799B (it) * 1990-03-15 1993-12-17 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche contenenti 3-metiltiopropionil l-carnitina ad attivita' sul sistema cardiovascolare.
DE10026666A1 (de) * 2000-05-29 2001-12-20 Gunther Burgard Verwendung von Hyaluronidase zur Prophylaxe und Behandlung von Herz-Kreislauf-Erkrankungen
US7700074B2 (en) * 2002-02-07 2010-04-20 Pettegrew Jay W Method and system for diagnosis of neuropsychiatric disorders including chronic alcoholism
US7407778B2 (en) * 2002-02-07 2008-08-05 Pettegrew Jay W Compounds, compositions and methods for treating neuropsychiatric disorders
US20060257842A1 (en) * 2003-05-29 2006-11-16 Pettegrew Jay W Cryopreservation media and molecules
DE602004022301D1 (de) * 2003-05-29 2009-09-10 Jay W Pettegrew Glycerophosphocholin und derivate davon zur medizinischen abbildung von neuropsychiatrischen erkrankungen
CN101336914B (zh) * 2007-07-03 2011-12-28 常州高新技术产业开发区三维工业技术研究所有限公司 一种缩小心肌梗死面积的药物组合物及其应用
CN119390599A (zh) * 2024-10-28 2025-02-07 诚达药业股份有限公司 一种乙酰左旋肉碱盐酸盐衍生物及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE948159C (de) * 1953-05-08 1956-08-30 Laboratoires Labaz Soc D Verfahren zur Herstellung von bimolekularem Carnitinchlorid
GB754873A (en) * 1953-05-08 1956-08-15 Laboratoires Labaz Soc D Dicarnitine dichloride and a process for the preparation thereof
IT1116037B (it) * 1979-04-23 1986-02-10 Sigma Tau Ind Farmaceuti Esteri e ammidi di acil carnitine loro procedimenti di preparazione e loro uso terapeutico
IT1147079B (it) * 1980-05-30 1986-11-19 Sigma Tau Ind Farmacuetiche Ri Esteri di alcossi-acil derivati della carnitina procedimento per la loro preparatione e composizioni farmaceutiche che li contengono
IT1145371B (it) * 1980-05-30 1986-11-05 Sigma Tau Ind Farmaceuti Alcossi-acil carnitine procedimento per la loro preparazione e composizioni farmaceutiche che le contengono

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5418253A (en) * 1992-10-20 1995-05-23 Avantgarde S.P.A. Esters of L-carnitine and alkanoyl L-carnitines with glycolic acid or esters thereof and pharmaceutical compositions containing same for treating dermatoses

Also Published As

Publication number Publication date
IT1177874B (it) 1987-08-26
IL75625A0 (en) 1985-10-31
DE3522534A1 (de) 1986-01-09
IT8448503A0 (it) 1984-07-04
CH664561A5 (it) 1988-03-15
IT8448503A1 (it) 1986-01-04
JPS6130560A (ja) 1986-02-12
US4743621A (en) 1988-05-10

Similar Documents

Publication Publication Date Title
DZ1077A1 (fr) Nouvelles préparation pharmaceutique pour administration orale.
FR2582513B1 (fr) Compositions pharmaceutiques contenant de l'alfuzosine
MY101791A (en) New benzimidazole derivatives
OA08481A (fr) Dérivés d'indolizine, leur procédé de préparation ainsi que les compositions les contenant.
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
BE849632A (fr) Composition pharmaceutique pour l'administration orale
IT8621358A0 (it) Composizione farmaceutica adattivita' analgesica.
OA08647A (fr) Dérivés d'imidazole, procédés pour leur préparation et composition pharmaceutique les contenant.
MY101784A (en) Novel pharmacological compounds
AU1578688A (en) Pharmaceutical composition, for oral administration, designed to attenuate the effects of beta-lactamines
BE902796A (fr) Ester d'acetyl carnitine, sa preparation et son utilisation.
BE1002151A5 (fr) Nouveaux derives de l'acide furannuronique, leur preparation et leur utilisation comme medicaments.
OA07525A (fr) Dérivés d'acides-animés, leur préparation et utilisation ainsi que les compositions contenant ces dérivés.
ES2062137T3 (es) Utilizacion de 5'-deoxi-5'-metil-tioadenosina, s-adenosilmetionina y sus sales para la preparacion de composiciones farmaceuticas reductoras de seborrea.
FR2607502B1 (fr) Derives de l'imidazole, leur preparation et compositions medicamenteuses les contenant
OA07539A (fr) Nouveaux dérivés d'acides phényl aliphatiques, leur préparation, leur application comme médicaments, et les compositions les renfermant.
FR2660192B1 (fr) Formulation liposomiales pour l'administration topique ou vaginale de medicaments.
NZ220747A (en) Pharmaceutical compositions containing 1,3-oxazolidin-2- one derivatives
OA08406A (fr) Préparation de combinaison pour le traitement de la malaria.
PT84399A (en) Process for the preparation of pharmaceutical compositions containing sodium 2-(2,6-dichloroanilino) phenylacetate
MY101821A (en) Quinazolinediones and pyridopyrimidinediones
FR2580649B1 (fr) (-) - 1b - ethyl - 1a - hydroxymethyl -1,2,3,4,6,7,12,12ba-octahydroindolo(2,3-a) quinolizine, procede pour la preparer et compositions pharmaceutiques contenant celle-ci
FR2609392B1 (fr) Compositions pharmaceutiques contenant des pyranoquinoleines
FR2585953B1 (fr) Composition pharmaceutique pour l'administration orale contenant de l'ubiquinone et procede
ES8801267A1 (es) Procedimiento para preparar derivados de isoquinolinona

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.

Effective date: 19940731